Related Experiment Video
Updated: Aug 3, 2026
Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation
Published on: August 13, 2013
8-Cl-adenosine induces differentiation in LS174T cells
C C Carlson1, L L Burnham, R A Shanks
1Department of General Surgery, Medical College of Georgia, Atlanta 30912, USA [corrected].
Abstract:
8-Cl-adenosine represents a novel nontoxic chemotherapeutic agent shown to inhibit growth of a number of colorectal cancer cell lines. We have utilized the mucin-secreting colorectal cancer cell line, LS174T, to assess the growth inhibitory properties of 8-Cl-adenosine independent of its parental compound, 8-Cl-cAMP. Conversion of 8-Cl-cAMP to 8-Cl-adenosine is required for growth inhibition in LS174T cells. 8-Cl-Adenosine inhibited growth by inducing a G1 cell cycle arrest that was associated with large (eightfold) increases in p21WAF1/Cip1 and p53 protein levels and a decrease in the phosphorylation status of the retinoblastoma protein. LS174T cells did not undergo apoptosis. In addition, 8-Cl-adenosine also induced some degree of enterocytic differentiation. Both villin protein levels as well as alkaline phosphatase activity rose (2- and 3.5-fold, respectively) in response to treatment with 8-Cl-adenosine. Our results suggest that in LS174T cells, 8-Cl-adenosine not only serves as a growth inhibitory agent but also as an inducer of enterocytic differentiation.
Insights
8-Cl-adenosine effectively inhibits colorectal cancer cell growth by halting the cell cycle and promoting differentiation. This novel agent, 8-Cl-adenosine, shows promise as a non-toxic chemotherapeutic for colorectal cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Colorectal cancer (CRC) remains a significant global health challenge.
- Novel chemotherapeutic agents are needed to improve treatment outcomes.
- 8-Cl-adenosine has shown potential as a growth inhibitor for various cancer cell lines.
Purpose of the Study:
- To investigate the growth inhibitory effects of 8-Cl-adenosine on the LS174T colorectal cancer cell line.
- To determine the mechanism of growth inhibition, including cell cycle effects and differentiation.
- To assess the role of 8-Cl-adenosine independently of its precursor, 8-Cl-cAMP.
Main Methods:
- Treatment of LS174T cells with 8-Cl-adenosine.
- Analysis of cell cycle progression using protein level assessments (p21WAF1/Cip1, p53, retinoblastoma protein phosphorylation).
- Evaluation of enterocytic differentiation markers (villin protein, alkaline phosphatase activity).
Main Results:
- 8-Cl-adenosine inhibited LS174T cell growth by inducing a G1 cell cycle arrest.
- Significant increases in p21WAF1/Cip1 and p53 protein levels were observed.
- Treatment led to increased villin protein and alkaline phosphatase activity, indicating enterocytic differentiation.
- No apoptosis was induced in LS174T cells.
Conclusions:
- 8-Cl-adenosine is a potent inhibitor of colorectal cancer cell growth.
- The mechanism involves G1 cell cycle arrest and induction of enterocytic differentiation.
- 8-Cl-adenosine represents a promising non-toxic chemotherapeutic agent for colorectal cancer.
